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Abstract 
Purpose:  To investigate the congruency of the retinal ganglion cell structure – function 
relationship in the macular region of human subjects who manifest horizontal split fixation 
due to glaucoma.  Subjects with glaucoma who manifest asymmetric loss of retinal 
ganglion cells across the horizontal meridian macula were examined using structural 
measures provided by spectral domain optical coherence tomography (SD-OCT) and 
functional measures using automated visual field perimetry (HVF). Using this data, the 
horizontal meridian of the human macula was defined using structure – function linking 
analysis of retinal ganglion cell integrity.   
 
Methods: 26 stable glaucoma subjects who manifest split fixation on HVF 24-2 S/S testing 
were identified and performed Heidelberg Spectralis® SD-OCT posterior pole asymmetry 
analyses. The posterior pole asymmetry analysis image was oriented in a systematic 
manner so that the macular thickness grid was centered on the fovea and its horizontal 
meridian intersected the optic nerve head at five pre-selected equidistant locations along 
the central vertical axis. The posterior pole asymmetry analysis for each optic nerve head 
intercept generated average superior and inferior retinal hemifield and temporal quadrant 
thicknesses and the superior to inferior thickness ratio calculated. 
 
Results: The subjects had a Humphrey Visual Field 24-2 SITA Standard (HVF S/S) 
average Mean Defect = 7.43 (SD = 4.58) and an average Pattern Standard Deviation = 
9.60 (SD = 2.77). A one-way repeated measures ANOVA demonstrates a significant 
difference between the optic nerve head intercept locations for the hemifield ratios [F(4, 
26)=19.37, p<.0001], as well as for the temporal quadrant ratios [F(4,16)=13.3, p <.0001]. 
Tukey post-hoc pairwise comparisons of the hemifield and quadrant thickness ratios 
demonstrate a significant difference between the superior and inferior poles (p<.01). The 
SD-OCT thickness ratios for both the hemifield and temporal quadrants increase as the 
horizontal meridian migrates towards the inferior pole of the optic nerve head. 
 
Conclusions: We demonstrate that in order to maximize the hemifield ratio and the 
congruency of the macular structure - function relationship in subjects with glaucoma, the 
horizontal meridian of the posterior pole asymmetry grid should intersect the optic nerve 
head near the inferior pole. This is in contradistinction to the conventional practice of 
placing the horizontal median through the geometric center of the optic nerve head.  
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Introduction 
Glaucoma is defined as a characteristic optic neuropathy with characteristic visual field 
loss. 7-9 Glaucomatous optic neuropathy is due to the loss of retinal ganglion cell (RGC) 
axons with subsequent loss of vision.  Glaucoma is the second leading cause of blindness 
worldwide and affects an estimated 60 million people in 2010.5,6 
 
The loss of RGC activity leads to characteristic patterns of vision loss and blindness.  The 
visual field represents the functional correlate of glaucoma. 1, 12 Early in the disease 
process the visual field may appear full and healthy.  13, 14 As the disease progresses with 
continued loss of RGC activity, the visual field is degraded and this loss negatively impacts 
the patient’s quality of life. 15-17 
 
Please refer to Figures 1a-d that aid in describing the linkage between the anatomical-
structural changes at the optic nerve head, retinal nerve fiber layer and functional visual 
field performance in a patient with glaucoma. 
 
The anatomical correlates of RGCs are represented by the thickness of the 1) macular, 2) 
retinal nerve fiber layer and 3) retinal ganglion cell layer as measured by optical coherence 
tomography.  These anatomical correlates are known to diminish in thickness and volume 
as a result of glaucoma (monkey 18, 19, human 20-33).  We used a Heidelberg spectral 
domain – optical coherence tomography (SD-OCT, Spectralis®) device to quantitatively 
measure these structures noninvasively in the living human eye. 34, 35(Figures 1b & 1c) 
 
Retinal ganglion cells transmit visual signals from the retina through the optic nerve to the 
higher brain centers, which provide for our perception of the visual world.  The function of 
retinal ganglion cells is represented by the subject’s performance on automated visual field 
testing.  Because retinal ganglion cell distribution is highly organized topographically 
across the retina and within the optic nerve, the pattern of visual field sensitivity correlates 
well with the presence and absence of retinal ganglion cell activity at a given location in 
the retina.  Thus, loss of retinal ganglion cells in a given region of the retina leads to a 
representative loss of sensitivity in the visual field. (monkey36, human13, 14, 37) (Figures 1a & 
1d)  This forms the basis of the structure - function relationship between RGC location and 
functional visual field performance. 
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The visual field is psychophysically measured using computer-assisted devices in an 
automated, noninvasive fashion.38 We utilized the Humphrey Visual Field Analyzer (HVA-
II®, Carl Zeiss Meditec Inc, Dublin, CA, USA). 
 
We conducted a structure – function analysis of human retinal ganglion cell (RGC) 
integrity.   This study is intended to provide a better understanding of the structure – 
function relationship between: (1) macular thickness (structural anatomy) and (2) visual 
field performance (psychophysical function).  We are evaluating the congruency of the 
topographic alignment of RGCs across the human macula region with its functional, 
psychophysically, derived visual performance.  These topographic and psychophysical 
measurements were performed on the same eye to minimize between inter-subject 
confounding factors and enhance capture of meaningful data.  
 
 
 
Background 
Visual perception is the product of an intricate neuronal processing beginning in the retina 
and proceeding to higher brain centers. Images enter the eye as photons of light and are 
focused by the lens onto the retina where the photoreceptor cells transduce the capture of 
photons into electrical signals. These signals are processed in the layers of the retina 
resulting in transmission of bioelectrical signals to the brain through the optic nerve. The 
optic nerve represents the final common pathway for visual information transmission from 
the eye to the brain.  The optic nerve is made up of bundles of retinal ganglion cell (RGC) 
axons which originate from cell bodies in the retina and then coalesce and exit the back of 
the eye to form the optic nerve.  (Figure 2)  Diseases of the optic nerve represent damage 
to the retinal ganglion cell axons.  When a critical number of retinal ganglion cell axons 
become damaged or die, visual function can be degraded to the point of blindness and 
thus negatively impact the quality of life for the patient.  
 
Retinal ganglion cells in the inner retina and their axons in the optic nerve are 
topographically distributed in a highly organized fashion and tightly linked with the 
resultant visual space perceived by the individual.21 Thus, there is an organized linkage 
between the structural distribution of retinal ganglion cell axons and the function of the 
optic nerve itself 47.  Visual field sensitivity correlates well with the presence and absence 
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of retinal ganglion cell activity at a given location in the retina. Damage to a specific region 
of retinal ganglion cells in the retina or axons in the optic nerve head leads to a 
representative loss of sensitivity in the visual field. The reverse is also true with the ability 
to trace visual field loss to a specific portion of the optic nerve head. This relationship 
between the location of RGCs and their axons with their visual field locations forms the 
structure - function relationship we are exploiting in this study.  Our goal is to examine this 
relationship; questioning whether current assumptions of the topographic structure – 
function alignment is correct and to suggest necessary changes in order to improve the 
congruency of the retinal ganglion cell structure – function relationship in the human 
macular region. 
 
Spectral domain optical coherence tomography (SD-OCT) provides non-invasive detailed 
imaging of the structures of the retina. With the advent of SD-OCT we are able to obtain 
high-resolution images of the retinal layers from the inner limiting membrane to Bruch’s 
Membrane.  SD-OCT uses near infrared light to acquire micrometer resolution three-
dimensional images of biological tissue2.  The topographic correlates of RGC activity are 
represented by the thickness of the macula, retinal nerve fiber layer, and retinal ganglion 
cell layer as measured by optical coherence tomography (OCT)13.  These anatomical 
correlates are known to diminish in thickness and volume as a result of glaucoma27.  In 
this study, loss of RGCs due to glaucoma is measured using SD-OCT macular thickness 
asymmetry across the horizontal raphe within a given eye. 
 
Psychophysical testing, using a Humphrey visual field analyzer (HVA),  is accomplished by 
presenting the subject with standard white on white stimuli under standardized testing 
conditions to measure visual field performance and provides the functional correlate of 
RGC activity21.  
 
This study examines macular structure and function for a variety of reasons. Chief among 
them is that 80% of the RGCs in the human retina are located within the macular region. 
Furthermore, there is variation of the RGC distribution in the retina among the human 
population and the macula is strong candidate for the site of least variability50.  In addition, 
we chose to focus on total macular thickness because the current commercially available 
software automatically calculates macular thickness with high reliability and low variability 
from the inner limiting membrane to Bruch’s membrane. 
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In order to better correlate functional visual field loss to the structural loss seen on OCT 
testing a more precise understanding of the structure function relationship between these 
overlapping measures of RGC integrity is needed. We attempted to guide standardization 
for the measurement and continued monitoring of RGC structural distribution in the human 
macular region. We used glaucoma subjects as a model to investigate the RGC structure - 
function relationship in the human macula. We hypothesized that the asymmetric visual 
field loss across the horizontal raphe typical of the glaucomatous disease process will be 
reflected in an SD-OCT macular hemifield difference and thus define the anatomic 
horizontal meridian of the human macula (Figure 2a-d).  We leveraged this presumed 
asymmetric RGC loss by examining patients who manifest significant asymmetric visual 
field loss within the macular characterized by split fixation. (Figure 2d) 
 
 
Protocol 
Clinical Data to Date 
Much of the structure - function  findings reviewed above is derived from cross-sectional 
studies, examining groups of subjects at a single point in time during the disease process.  
Few studies have utilized within-subject control design, measuring neighboring areas of 
retina within the same eye as a control.  Our study incorporates this design feature in order 
to help mitigate experimental noise found in inter-subject comparisons.  In addition, our 
testing procedures are designed to capture same-eye control data during a single data 
collection session. 
 
We planed to measure various structural and functional correlates of retinal ganglion cell 
integrity with special attention given to central macular function which is responsible for 
fine acuity vision and tends to produce less variable results when measured. 
 
In general, optic neuropathies tend to affect the entire optic nerve.  However in specific 
cases, we plan to leverage the asymmetric loss of RGCs found in the same eye.  This 
characteristic asymmetry is typically manifest by RGC loss and visual field depression 
worse in one visual hemifield relative to the other and split along the horizontal meridian. 
(Figures 2a-d)  Our study design leverages this hemifield difference and we will analyze 
the structure - function discrepancies across the horizontal meridian in a given eye using 
two modalities 1) anatomical structure:  SD-OCT, and 2) psychophysical function:  HVA-II.  
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Few studies have leveraged this asymmetric loss of structure and function in the glaucoma 
patient (macular hemifield thickness compared to visual field hemifield performance41, 42). 
 
Performing these measurements in the same eye allows us to use each eye as its own 
control and enhance our ability to detect meaningful differences in the anatomy and 
psychophysical measurements that could otherwise be lost in sampling variability and 
detecting signal from noise inherent in our data acquisition equipment.  Collecting 
comparison data in the same macula region will lessen the influence of inter- subject and 
intra-ocular variability.  
 
By utilizing the asymmetric damage within a given eye, we can better characterize the 
interdependency between 1) macular thickness, and 2) visual field performance in the 
macula region of the human. 
 
Study Objectives Purpose 
The study is designed to examine RGC structure and function in subjects with 
glaucomatous optic neuropathy.  We utilized noninvasive techniques and devices that are 
not experimental in nature. We intended to: 
1) Measure the RGC structure in the macula and nerve fiber layer utilizing the 
Heidelberg SD-OCT Spectralis® device. 
2) Measure central visual field function utilizing a standard HVA-24 Sita-Standard 
automated perimetry testing paradigm. 
 
The study design allowed for structure - function comparisons to be made: 
1) Within the same study eye 
2) Between eyes of the same subject and  
3) Between eyes of separate subjects 
 
This study provides for a foundation of future studies that are planned to characterize the 
short and long term structure – function changes of retinal ganglion cell integrity in 
subjects with various optic neuropathies. 
 
 
General Design 
This is a nonrandomized, prospective, observational study designed to correlate the 
structural and functional surrogates of the retinal ganglion cell integrity in the human 
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retina.  Subjects were provided the usual evaluation and care for their optic neuropathy 
and any other underlying ocular conditions.  When appropriate, both eyes of the subject 
underwent examination and testing.  The timing and frequency of exames and data 
collection followed the usual care practice of the attending physician and were directed by 
the degree and stability of the patient’s optic neuropathy. Care included standard imaging 
of the optic nerve head region and macula using the Heidelberg SD-OCT Spectralis® 
device and assessment of visual field performance utilizing the HVA 24-2 S/S testing 
protocol. Each of these noninvasive clinical tests were performed by certified ocular 
photographers adept at performing these studies. All studies were performed at the 
Department of Ophthalmology, Ochsner Clinic, 1514 Jefferson Highway, New Orleans, LA, 
USA. 
 
Study Endpoints 
Primary Study Endpoints 
This study represents our initial attempt to systematically collect and follow correlates of 
retinal ganglion cell structure and function in the human retina.  Since subjects recruited 
for this study have advanced glaucoma and are very familiar with the testing algorithms, 
we anticipate that single exam sessions will be sufficient to capture SD-OCT images and 
HVA 24-2 S/S performance.  However, for some subjects, the reliability or quality of the 
collected data may be such that a repeat of some or all of these tests will be required. 
Repeated measures for unreliable clinic data are typical and usual for many 
ophthalmology subjects. 
 
 
Secondary Study Endpoints 
With regard to optic neuropathies and glaucoma specifically, in general, visual field 
performance is directly related to macula and retinal nerve fiber layer thickness; the thicker 
the retina and nerve fiber layer the better visual field performance.  However, this 
relationship may not be strictly linear such that early in the glaucomatous disease process, 
visual field performance tends to be better than that suggested from thinning of the retina 
and RNFL. (monkey 18, 19, human 20-33) By the time visual field defects are detected, up to 
30% of the optic nerve can be damaged.13, 14 It is unclear why visual field performance 
tends to be more robust and resistant to change compared to optic nerve head structure in 
some patients with glaucoma. 47, 48 
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In addition, later in the glaucoma disease process, the visual field performance is more 
degraded than predictions based upon structural measure – given the thickness of the 
retina and nerve fiber layer, the visual field should be better than observed.  The 
suggestion here is that the nerve fiber layer ceases to thin and is repopulated by glial cells 
as the RGCs die. 46 
 
Our study is a step in providing answers regarding the discrepancies in the linkage 
between the structure and function of retinal ganglion cell integrity in the human retina. 
 
Primary Safety Endpoints 
Our study utilizes non-invasive techniques with low anticipated risks to the subjects. The 
subjects in this study will undergo usual and accepted evaluations provided to subjects 
with glaucoma. Should any adverse effect(s) be noted while undergoing these routine 
clinical tests, the study will be suspended until such time as the cause of the adverse 
effect(s) is identified and corrected.  
 
Subject Selection and Withdrawal 
Inclusion Criteria 
Subjects diagnosed with glaucoma; 
AND  
Subjects with a best-corrected visual acuity of 20/40 or better in at least one eye 
AND 
Subjects are able to provide reliable visual field performance using the HVA 24-2 S/S 
testing algorithms 
AND 
Subjects without significant ocular pathology affecting retinal thickness or retinal image 
quality. 
 
Exclusion Criteria 
Poorly controlled ocular disease of any sort in either eye 
OR 
Subjects with a best-corrected visual acuity worse than 20/40 in the better eye 
OR 
Subjects unable to provide reliable visual field performance using the HVA 24-2 testing 
algorithms 
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OR 
Subjects with significant ocular pathology affecting retinal thickness or retinal image quality 
 
 
Control subjects without ocular disease as determined by an experienced ophthalmologist 
will also be included. These subjects must satisfy all inclusion and exclusion criteria except 
those related to ocular disease. 
 
Subject Recruitment and Screening 
Following IRB approval, subjects who are to the patients of Dr. Jonathan D. Nussdorf, the 
principle investigator, were recruited from the Department of Ophthalmology, Ochsner 
Medical Center in New Orleans for consideration of inclusion to this study.   The selection 
of subjects were not be made in random fashion.  Potential subjects were identified by the 
principle investigator as those who have stable, well controlled glaucoma and would be 
able to cooperate with the proposed non-invasive tests and who were likely to perform 
reliably well on visual field testing.   Subjects were identified and consented for 
participation in this study prior to or at the time of their first study visit by the principle 
investigator. 
 
Early Withdrawal of Subjects 
Subjects may withdraw from this study at any point in time. 
 
When and How to Withdraw Subjects 
Subjects will be withdrawn immediately and at any time at their request.  Subjects will be 
withdrawn if they exhibit a change in their underlying ocular pathology that would interfere 
with the reliability of the data collected; in this case the decision to withdraw will be at the 
discretion of the principle investigator. 
 
Data Collection and Follow-up for Withdrawn Subjects 
Subjects in this study will continue to receive the usual care provided to any patient with 
glaucoma.  Any data that may have already been accumulated will continue to be used 
unless the subject specifically requests otherwise. 
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Statistical Plan 
Sample Size Determination 
We planned to have ongoing recruitment of subjects with various optic neuropathies over 
the years.  We planned to perform short term cross sectional studies and long term studies 
to evaluate outcomes and risk factors for progression. 
 
Statistical Methods: 
Correlation data analysis 
Least Squares Regression analysis 
ANOVA  
 
Subject Population(s) for Analysis: 
Subjects with glaucoma were recruited from the Department of Ophthalmology, Ochsner 
Clinic Foundation, New Orleans. 
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Study Design 
This study was conducted according the tenets of the Declaration of Helsinki and was 
approved by the Ochsner Clinic Foundation’s institutional review board. All subjects gave 
informed consent to participate in the study.  
 
 
Population 
Twenty-six subjects with well controlled, stable glaucoma and who manifest central visual 
field loss confined to a single retinal hemifield respecting the horizontal meridian (also 
referred to split fixation). For the purpose of this study the visual field loss was defined as a 
cluster of 3 or more points that were all worse than the .05 probability level on the total 
and/or pattern deviation plots. 
 
Subjects were recruited from the glaucoma service of a single provider (JD Nussdorf) at 
Ochsner Medical Center in New Orleans. Subjects were selected for inclusion in the study 
in a non-random manner at the discretion of the investigator. All subjects in the study 
underwent a complete ophthalmic evaluation including, best corrected visual acuity 
refraction, SD-OCT imaging, fundus photography, and a dilated fundus exam prior to 
selection for inclusion in the study, and standardized Humphrey Visual Analyzer (HVA) 
testing. Subjects were also required to have a best-corrected visual acuity greater than 
20/40 in the better eye. Subjects were required to have well controlled glaucoma with 
intraocular pressure near the target range and without evidence of progressive retinal 
nerve fiber layer or visual field loss. Subjects were excluded if they had a history of retina 
disease other than glaucoma including hypertensive changes, cystoid macular edema, 
diabetic retinopathy, macular degeneration, epiretinal membrane, optic neuropathies other 
than glaucoma, or any other disease affecting the macula. Subjects were excluded if they 
had received treatment with any intravitreal injections or retina laser procedures.  Subjects 
with visually significant cataracts that could interfere with retinal imaging or HVA 
performance were excluded. Subjects with prior cataract surgery were accepted if the 
surgery was at least 6 months in the past with no ongoing complications, however any 
other ocular surgery resulted in exclusion from the study. Subjects were required to be 
non-naïve to HVA testing and were excluded if they were unable to provide reliable 
performance on HVA 24-2 SITA standard testing algorithm. HVA testing was deemed 
reliable using the guidelines set out by the ocular hypertension treatment study. Namely, 
subjects were required to have less than 33% false positives, less than 33% false 
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negatives, and less than 33% fixation loses. HVA testing was conducted by trained 
technicians who monitored and coached the subjects during testing. All study related 
testing must have been completed within a period of 3 months to qualify for inclusion. In 
subjects where both eyes met inclusion criteria a single eye was randomly chosen for 
inclusion.  Controls were recruited from among subjects and staff of Ochsner Medical 
Center and met identical criteria as subjects except for the presence of glaucoma.  
 
 
 
 
 
 
Methods 
All subjects were imaged using the unmodified posterior pole asymmetry analysis protocol 
of the Heidelberg Engineering Spectralis® SD-OCT (Heidelberg Engineering, Carlsbad, 
CA). Subjects were asked to look at a blue fixation target in the camera that centered the 
scan on their fovea. For the purposes of this study the fovea was defined as the center of 
the foveal pit. The scan covered an area of the retina of 30 by 25 degrees centered on the 
fovea. The scan provided 61 B-scans 120 um apart for each scan, with an optical 
resolution of 7 um axially and 14 um laterally. The resulting image covers a 24 by 24-
degree retinal region and is divided into 64 cells with each cell representing the average 
retinal thickness of a 3 by 3 degree region. The Spectralis® software provided auto-
segmentation of the retinal layers between the internal limiting membrane and Bruch’s 
membrane. In 1 case where the software was unable to perform this task the investigator 
segmented the layers manually.  
 
The grid was then manipulated in a systematic manner such that it was centered on the 
fovea and the horizontal meridian aligned with 5 predetermined intercepts through  the 
vertical axis of the optic nerve head (ONH). The locations of the intercepts were chosen to 
encompass the entire breadth of the ONH, spanning from the superior pole and 
progressing to the inferior pole of the ONH. The intercepts were: the superior pole of the 
ONH, half way between the superior pole and the mid-point of the ONH, the mid-point of 
the ONH, half way between the mid-point of the ONH and the inferior pole, and the inferior 
pole of the ONH (Figure 6). For each alignment setting, the Spectralis® software 
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generated average macular thicknesses for the superior and inferior retinal hemifields. 
These average thicknesses were then used to create a “hemifield ratio” of superior to 
inferior average macular thickness when the inferior macular thickness was thinner than 
the superior macular thickness.  A “temporal quadrant ratio” was similarly calculated using 
the average thicknesses of the superior temporal and inferior temporal quadrants of the 
macular thickness grid. In cases when the inferior macular thickness was thicker than the 
superior macular thickness then the ratio was flipped to produce a macular thickness 
ration greater than one. When subjects exhibited inferior visual field loss, and thus 
superior macular thinning, the calculation was inverted such that the ratio was calculated 
as inferior retinal thickness over superior retinal thickness. This was to ensure the ratio 
remained greater than one and congruent with the results of patients with superior visual 
field loss. 
 
 
 
Results 
 
Twenty-six eyes of 26 subjects were tested and there were 20 females and 6 males with 
an average age of 64 years old. The subjects had an HVA 24-2 S/S average Mean 
Defect=7.43 (SD= 4.58) and an average Pattern Standard Deviation=9.60 (SD=2.77) 
(Figure 5). The hemifield and quadrant ratios for the different ONH intercepts are listed in 
figure 8.  A one-way repeated measures ANOVA demonstrates a significant difference 
between the intercept locations for the hemifield ratios [F(4, 26)=19.37, p<.0001] (figure 3), 
as well as for the temporal quadrant ratios [F(4,16)=13.3, p <.0001] (figure 4).  
 
Tukey post-hoc pairwise comparisons of the hemifield and quadrant thickness ratios 
demonstrate a statistical significant difference between the superior and inferior poles 
(p<.01) and the superior pole and halfway between the midpoint of the ONH and the 
inferior pole (p<.01).  The thickness ratios for both the hemifield and temporal quadrants 
increase as the horizontal meridian migrates from the superior pole towards the inferior 
pole of the ONH and reaches a maximum near the inferior pole. Tukey post-hoc 
comparisons were used without the Bonferoni correction in an attempt to remain as 
conservative as possible with our statistical analysis.  
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The controls had 12 eyes of 6 subjects tested and there were 4 females and 8 males with 
an average age of 41years old. The controls had an HVA 24-2 S/S average Mean 
Defect=0.537 (SD=0.35) and an average Pattern Standard Deviation=1.175 (SD=0.36) 
(Figure 5). A one-way repeated measures ANOVA demonstrates no difference between 
the horizontal intercept locations for the hemifield ratios [F(4,6)=0, p=1] (Figure 3), as well 
as for the temporal quadrant ratios [F(4,6)=0, p=1] (Figure 4). The thickness ratios for both 
the hemifield and temporal quadrants trended towards 1 as the horizontal meridian 
migrates from the superior pole towards the inferior pole of the ONH and reaches 1 near 
the inferior pole.  
 
 
 
Discussion 
Our study analyzed subjects with glaucoma who exhibit split fixation on HVA 24-2 S/S to 
help define the anatomic horizontal raphe of RGC distribution in the human macula. We 
chose these subjects because they have a unique presentation such that their functional 
loss is heavily weighted to a single retinal hemifield and respects the horizontal meridian. 
The primary result of our study is that the structural horizontal raphe determined by SD-
OCT does not intersect the geometric center of the optic nerve head in our subject 
population.   The alignment of the SD-OCT posterior pole asymmetry scans with the center 
of the optic nerve fails to maximize the congruence of the structure - function relationship.   
 
 
In subjects with split fixation, we demonstrate that the structural asymmetry as measured 
by SD-OCT hemifield ratio increases as the ONH intercept moves towards the inferior 
pole. In other words, as the ONH intercept of the macular thickness grid moves towards 
the inferior pole of the ONH, the difference between the macular superior and inferior 
hemifield thicknesses is maximized. In the control population, the hemifield ratio trends 
towards 1 as the macular thickness grid’s horizontal intercept moves towards the inferior 
pole and reaches 1 near the pole. A hemifield ratio of 1 demonstrates no difference in 
macular thickness between the superior and inferior hemifields and is what one would 
expect in a healthy subject without glaucomatous damage. 
 
For the glaucoma subject with HVA split fixation, these results demonstrate that as the 
horizontal meridian of the macular thickness grid moves from the superior portion of the 
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optic nerve towards the inferior pole, the difference between macular hemifield 
thicknesses increases.  However, in control subjects, a similar adjustment of the horizontal 
meridian minimizes the hemifield ratio.  These results demonstrate that the concordance 
between the anatomic and functional correlates of RGC distribution in the human macula 
increases as the horizontal raphe intersects the inferior portion of the optic nerve head. 
 
In order to avoid the influence of the papillomacular bundle the temporal quadrant ratio 
was determined. The temporal quadrant ratio demonstrated a similar pattern of results to 
the hemifield ratio. In subjects with split fixation, the difference between the superior and 
inferior temporal quadrant thickness increases as the horizontal meridian of the macular 
thickness grid migrates toward the inferior pole of the ONH. In addition, for the control 
subjects the temporal quadrant ratio approached 1 as the horizontal meridian of the 
macular thickness grid moves towards the inferior pole of the ONH.  
 
Together our findings demonstrate that the anatomic horizontal meridian of the human 
macula lies in an alignment between the fovea and the inferior portion of the ONH. We 
demonstrate that in both subjects with split fixation and control subjects normal SD-OCT 
and HVA testing the accurate horizontal alignment of the SD-OCT macular grid is along a 
line between the center of the fovea and intersecting near the inferior pole of the ONH.  
 
While we would like to be more precise in our delineation of the horizontal meridian the 
limitations imposed by examining only five ONH intercepts prevents this. However, we can 
say with certainty that aligning the horizontal median through the geometric center of the 
optic nerve is not anatomically sound. The structural correlate of the horizontal raphe of 
the human macula intersects the inferior region of the ONH in contradistinction to the usual 
clinical assumption that the RGC fiber distribution corresponds with the geometric center 
of the ONH. 51  
 
 
Conclusion 
We demonstrate that in order to maximize the congruency of the macular structure - 
function relationship in our subject pool, the horizontal meridian of the SD-OCT posterior 
pole asymmetry grid centered on the fovea intersects the inferior pole of the optic nerve 
head. This is in contradistinction to the usual practice of placing the horizontal median 
through the geometric center of the optic nerve head. This alignment of the macular 
25 
thickness grid provides a more accurate anatomic representation of the RGC distribution in 
the macula and will improve detection and monitoring progression of RGC loss. 
Furthermore, an anatomically accurate alignment will improve our understanding of the 
structure - function relationships present in the human macula.  
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Figure 1a      Figure 1b   Figure 1c 
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Figure 1d 
 
 
 
 
 
 
 
 
 
Figure1a: Color fundus photo of a left eye with 
anatomic-structural damage due to glaucoma. 
Note the inferior notch between the 5:00 – 6:00 
position (arrow) of the optic nerve and the 
inferior wedge shaped defect in the retinal nerve 
fiber layer (RNFL) (arrow heads) 
Figure 1b: An SD-OCT representation of RNFL 
with notching correlating with that seen in the 
color photo. 
Figure 1c: An SD-OCT representation of the 
hemifield macular thickness asymmetry map 
demonstrating thinning of inferior retina 
compared to the superior retinal hemifield. 
Figure 1d: An automated visual field of the left 
eye performed by this patient demonstrates 
functional superior visual field loss which 
correlates well with the structural damage in the 
inferior retina due to glaucoma. 
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Figure 2 Anatomic representation of the portion of the visual pathway within the human 
retina 
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Figure 3  Graph of ONH intercept (x axis) vs Hemifield Ratio (y axis) demonstrating the increasing 
superior to inferior hemifield ratio as the ONH intercept moves towards the inferior pole. Position 1 
is the intercept locations at the superior pole of the ONH, position 2 is the intercept located half-
way between the superior pole and the mid point of the ONH, position 3 is the mid-point of the 
ONH, position 4 is half-way between the mid-point of the ONH and the inferior pole and position 5 
is the inferior pole of the ONH. The red points represent the hemifield ratios of the subject from 
Figure 2.  
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Figure 4 Graph of ONH intercept (x axis) vs Temporal Quadrant Ratio (y axis) showing the 
increasing superior vs inferior temporal quadrant ratio as the ONH intercept moves towards the 
inferior pole.  Position 1 is the intercept locations at the superior pole of the ONH, position 2 is the 
intercept located half-way between the superior pole and the mid point of the ONH, position 3 is the 
mid-point of the ONH, position 4 is half-way between the mid-point of the ONH and the inferior 
pole and position 5 is the inferior pole of the ONH. The red points represent the quandrant ratios of 
the subject from Figure 2.  
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 Subjects Controls 
Average	  Age 64 41 
Males 6 8 
Females 20 4 
Average	  Mean	  Defect 7.43 0.537 
Average	  Pattern	  Deviation 9.60 1.175 
 	  	  Figure	  5	  Table	  of	  subject	  population	  demographics	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  Figure	  6	  SD-­‐OCT	  image	  of	  the	  posterior	  pole	  with	  macular	  thickness	  grid	  overlay.	  Black	  lines	  represent	  the	  5	  ONH	  intercepts	  used	  for	  the	  study.	  Numbers	  to	  the	  left	  of	  the	  image	  refer	  to	  ONH	  intercept	  positions.	  Position 1 is the intercept located at the superior pole of the ONH, 
position 2 is the intercept located half-way between the superior pole and the mid point of the ONH, 
position 3 is the mid-point of the ONH, position 4 is half-way between the mid-point of the ONH 
and the inferior pole and position 5 is the inferior pole of the ONH.	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  Figure	  7	  SPECTRALIS®	  SD-­‐OCT	  image	  illustrating	  the	  different	  retinal	  layers	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ONH Intercept Hemifield Ratio Temporal Quadrant Ratio 
1 1.047 1.031 
2 1.057 1.038 
3 1.063 1.044 
4 1.070 1.049 
5 1.079 1.053 	  Figure	  8	  Table	  with	  average	  hemifield	  and	  quadrant	  ratios	  at	  the	  five	  different	  ONH	  intercept	  locations.	  
 
